Skip to main content
. 2022 Dec 9;12(6):2202412. doi: 10.1002/adhm.202202412

Figure 9.

Figure 9

Immune cell populations in the TME from MC38 tumor‐bearing mice treated with QTPlus Ctrl and 3 mg kg−1 QTPlus‐AM21. A,B) QTPlus‐AM21 increased CD45+ tumor‐infiltrated immune cells and C,D) CD86+ M1 population in tumor microenvironment from MC38 syngeneic mouse model (n = 3). The green line in (B) indicates the plot differences in fluorescent intensity of Alexa Fluor 700‐conjugated CD45 from saline group to QTPlus‐AM21 group.